
News from lifesciencesbc.ca
Top lifesciencesbc.ca News

Business · CanadaAt 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with EP-104GI All Cohorts followed to 9 mon…See the Story
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis (EoE), Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI
67% Left coverage: 3 sources

Silver Spring · Silver SpringUnited Therapeutics Corporation (NASDAQ:UTHR) released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for idiopathic pulmonary fibrosis (IPF). The study met its primary efficacy endpoint of demonstrating improvement in absolute forced vital capacity (FVC) relative to placebo. FVC is a standard pulmonary function test. Tyvaso demonstrated superiority over placebo for the change in …See the Story
Why Is United Therapeutics Stock Rallying On Tuesday? - United Therapeutics (NASDAQ:UTHR)
Coverage: 2 sources